Pain relief with oral cannabinoids in familial Mediterranean fever

Anaesthesia
A HoldcroftF Evans

Abstract

Cannabinoids have analgesic and, possibly, anti-inflammatory properties but their clinical use has been restricted by legislation. This is the first United Kingdom report of the controlled use of a standardised pharmaceutical preparation of cannabinoids in capsular form. The therapy was assessed in a patient with familial Mediterranean fever, who presented with chronic relapsing pain and inflammation of gastrointestinal origin. After determining a suitable analgesic dosage, a double-blind placebo-controlled cross-over trial was conducted using 50 mg tetrahydrocannabinol daily in five doses in the active weeks and measuring effects on parameters of inflammation and pain. Although no anti-inflammatory effects of tetrahydrocannabinol were detected during the trial, a highly significant reduction (p < 0.001) in additional analgesic requirements was achieved. Future study designs can now incorporate prescribable forms of cannabinoids but the choice of previous cannabis users only as patients has clinical limitations. Cannabis naive patients would tolerate controlled investigations but may generate medicolegal problems.

Citations

Nov 19, 2004·Der Schmerz·R RukwiedC Konrad
Sep 7, 2006·Der Schmerz·C HampelC Spies
Apr 29, 2000·Prostaglandins & Other Lipid Mediators·V Di MarzoT Bisogno
Aug 17, 2002·Pharmacology & Therapeutics·Roger G Pertwee
Jul 3, 1999·Trends in Pharmacological Sciences·J ManzanaresJ A Fuentes
Feb 13, 2001·Progress in Neurobiology·R G Pertwee
Aug 17, 2002·Journal of Pain and Symptom Management·Avijit ChatterjeeMary-Ann Fitzcharles
Jun 5, 2003·Journal of Pain and Symptom Management·Mary E Lynch, Alexander J Clark
Oct 31, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Roger G Pertwee
Apr 29, 2005·International Journal of Clinical Practice·M A WareG W Guy
Sep 14, 2006·Pharmacological Reviews·Pál PacherGeorge Kunos
Jan 11, 2001·Drugs·E M Williamson, F J Evans
Mar 6, 2003·CNS Drugs·J Ludovic Croxford
Dec 15, 2010·Drugs·Matthias KarstJörg Ahrens
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·A ZimmerT I Bonner
Aug 28, 2014·Current Pain and Headache Reports·Perry G Fine, Mark J Rosenfeld
Jun 3, 2008·British Journal of Anaesthesia·R D Hosking, J P Zajicek
Sep 1, 2001·Expert Review of Neurotherapeutics·A Holdcroft, P Patel
Feb 25, 2009·Expert Opinion on Investigational Drugs·Matthias Karst, Sonja Wippermann
Jul 12, 2005·Expert Opinion on Investigational Drugs·Alyson Fox, Stuart Bevan
Jul 2, 2005·Expert Opinion on Emerging Drugs·J B CalixtoA R Santos
Jul 22, 2008·Rheumatic Diseases Clinics of North America·Mary E Lynch
Sep 22, 2005·British Journal of Haematology·Jo HowardSally C Davies
Feb 20, 2009·British Journal of Pharmacology·Roger G Pertwee
Feb 7, 2013·Pharmacotherapy·Laura M BorgeltGeorge S Wang
Mar 17, 2006·Journal of Ethnopharmacology·Mohamed Ben Amar
Apr 29, 2005·Journal of Pain and Symptom Management·Emily WoolridgeAnita Holdcroft
May 21, 2013·Drug and Alcohol Dependence·Mark A IlgenFrederic C Blow
Mar 23, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Suzanne NielsenBernard Le Foll
Sep 8, 2006·European Journal of Gastroenterology & Hepatology·Diana L SylvestreYvonne Malibu
Feb 2, 2006·The Annals of Pharmacotherapy·Tammy L Burns, Joseph R Ineck
Sep 22, 2010·American Journal of Physical Medicine & Rehabilitation·Diana H RintalaBrian M Bruel
Oct 6, 1998·Nature·I D MengH L Fields
Feb 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·P Robson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.